Evaluation of chemoprevention of oral cancer with Spirulina fusiformis.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/8584455
Conclusion of this study
Within one year of discontinuing supplements, 9 of 20 (45%) complete responders with SF developed recurrent lesions. Supplementation with SF did not result in increased serum concentration of retinol or beta-carotene, nor was it associated with toxicity. This is the first human study evaluating the chemopreventive potential of SF. More studies in different settings and different populations are needed for further evaluation.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study